We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPS5 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
2476.6
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
23045.4
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
9439.6
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
8957.5
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
8099.1
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
6962.5
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
6958.1
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
6410.1
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
6375.8
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
5824.3
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
5770.6
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
5746.4
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
5143.2
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
5010.8
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
4857.7
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
4768.6
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
4728.2
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
4706.3
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
4645.9
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
4593.2
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
4439.9
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
4434.6
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
4430.5
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
4418.3
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
4392.5
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
4346.6
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
4262.9
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
4217.5
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
4176.4
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
4172.2
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
4170.3
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
4150.7
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
4133.4
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
4107.8
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
3998.0
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
3979.8
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
3958.4
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
3956.6
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
3950.9
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
3909.1
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
3890.7
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
3886.4
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
3884.2
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
3863.0
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
3812.7
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
3812.3
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
3809.8
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
3756.1
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
3723.0
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
3680.7
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
3676.8
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
3658.8
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
3651.1
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
3649.6
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
3636.7
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
3608.2
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
3582.0
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
3574.1
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
3570.1
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
3564.3
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
3543.5
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
3496.6
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
3490.4
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
3476.4
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
3461.2
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
3461.0
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
3455.1
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
3404.1
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
3404.1
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
3396.4
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
3383.5
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
3324.6
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
3316.2
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
3299.0
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
3261.4
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
3254.1
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
3246.2
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
3237.9
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
3235.4
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
3235.0
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
3233.5
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
3214.1
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
3198.8
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
3175.2
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
3171.5
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
3164.9
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
3132.3
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
3130.3
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
3119.4
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
3115.6
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
3110.9
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
3094.0
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
3021.4
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
3004.9
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
2995.8
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
2989.0
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
2969.4
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
2966.9
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
2955.8
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
2932.3
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
2924.3
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
2884.9
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
2870.7
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
2868.0
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
2847.9
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
2845.5
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
2829.9
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
2825.0
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
2824.3
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
2819.5
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
2818.7
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
2804.9
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
2787.9
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
2777.6
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
2757.3
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
2752.0
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
2742.7
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
2733.9
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
2733.6
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
2729.9
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
2720.6
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
2685.3
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
2676.7
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
2673.9
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
2662.9
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
2653.6
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
2651.1
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
2648.1
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
2634.4
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
2632.1
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
2630.9
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
2614.2
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
2610.3
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
2610.1
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
2598.8
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
2590.6
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
2572.5
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
2566.9
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
2554.1
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
2536.9
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
2500.4
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
2465.8
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
2452.0
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
2443.4
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
2407.6
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
2405.0
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
2390.5
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
2346.5
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
2342.3
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
2309.9
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
2306.0
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
2301.2
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
2288.5
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
2275.2
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
2271.5
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
2253.2
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
2245.5
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
2243.6
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
2242.7
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
2212.2
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
2208.5
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
2208.5
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
2204.0
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
2203.3
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
2202.9
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
2198.4
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
2181.9
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
2167.9
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
2161.7
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
2155.2
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
2155.0
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
2138.5
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
2135.7
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
2128.6
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
2122.5
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
2122.1
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
2119.3
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
2117.9
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
2108.5
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
2107.6
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
2104.4
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
2102.9
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
2089.4
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
2087.8
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
2085.9
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
2084.9
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
2075.4
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
2044.8
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
2044.4
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
2044.0
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
2036.1
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
2020.9
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
2019.6
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
2004.4
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
1999.8
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
1993.8
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
1971.1
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
1962.2
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
1955.0
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
1949.3
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
1935.0
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
1930.9
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
1918.7
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
1909.4
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
1907.7
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
1907.0
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
1899.2
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
1899.0
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
1898.9
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
1895.3
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
1862.3
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
1848.2
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
1842.4
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
1829.7
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
1816.2
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
1816.2
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
1815.7
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
1815.0
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
1814.4
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
1811.7
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
1810.8
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
1798.0
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
1793.1
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
1782.7
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
1779.1
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
1763.1
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
1761.9
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
1760.6
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
1757.7
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
1730.8
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
1729.1
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
1728.3
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
1723.2
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
1713.3
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
1710.3
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
1702.9
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
1695.6
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
1692.7
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
1688.5
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
1679.5
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
1676.0
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
1673.0
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
1671.9
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
1670.4
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
1655.0
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
1649.4
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
1642.5
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
1640.6
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
1635.4
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
1634.8
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
1618.0
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
1608.1
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
1605.9
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
1600.8
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
1592.0
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
1572.5
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
1569.4
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
1565.9
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
1531.4
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
1529.4
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
1524.0
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
1515.9
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
1514.2
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
1511.0
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
1480.6
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
1476.3
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
1471.0
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
1454.6
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
1444.8
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
1435.2
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
1433.5
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
1430.9
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
1424.3
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
1408.4
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1384.7
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
1369.5
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
1360.9
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
1357.6
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
1352.8
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
1334.6
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
1329.5
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
1318.4
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
1306.9
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
1293.5
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
1291.4
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
1290.2
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
1273.2
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
1271.7
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
1265.1
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
1247.9
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
1246.9
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
1244.7
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
1244.0
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
1238.6
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
1238.0
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
1234.4
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
1234.0
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
1218.1
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
1210.5
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
1207.9
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
1193.4
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
1191.7
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
1179.9
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
1167.0
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
1161.0
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
1156.3
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
1151.5
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
1149.6
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
1148.6
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
1128.4
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
1127.5
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
1124.6
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
1112.8
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
1105.8
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
1098.6
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
1096.8
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
1096.8
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
1088.9
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
1068.9
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
1065.2
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
1054.4
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
1048.0
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
1028.2
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
1015.0
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
1005.8
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
1004.3
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
1000.9
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
975.7
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
969.8
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
933.7
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
894.7
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
855.9
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
849.1
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
840.7
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
810.8
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
806.5
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
790.2
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
788.9
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
787.8
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
785.6
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
785.2
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
769.8
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
746.8
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
731.6
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
720.5
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
701.5
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
680.0
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
642.1
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
590.4
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPS5 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
1533.7
Number of samples
81
Samples
Sample
Description
pTPM
DO46384
55 years, female, NA, stage:III, dead, 614 days
4646.5
DO46333
58 years, female, NA, stage:III, dead, 359 days
4285.5
DO46611
52 years, female, NA, stage:III, dead, 734 days
3699.7
DO46551
58 years, female, NA, stage:III, dead, 1055 days
3548.0
DO46568
66 years, female, NA, stage:III, dead, 320 days
3238.4
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
3189.9
DO46453
66 years, female, NA, stage:III, dead, 3294 days
2980.6
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
2853.3
DO46390
65 years, female, NA, stage:III, dead, 374 days
2672.3
DO46370
54 years, female, NA, stage:III, dead, 1727 days
2552.0
DO46331
72 years, female, NA, stage:III, dead, 612 days
2377.9
DO46463
49 years, female, NA, stage:III, dead, 2451 days
2154.3
DO46378
59 years, female, NA, stage:III, alive, 843 days
2142.5
DO46576
75 years, female, NA, stage:III, alive, 133 days
2129.3
DO46586
55 years, female, NA, stage:III, dead, 1019 days
2072.5
DO46402
77 years, female, NA, stage:III, dead, 511 days
2071.5
DO46338
59 years, female, NA, stage:III, dead, 596 days
2024.5
DO46364
45 years, female, NA, stage:III, dead, 806 days
1976.2
DO46326
51 years, female, NA, stage:III, dead, 701 days
1972.4
DO46566
78 years, female, NA, stage:III, dead, 673 days
1903.4
DO46388
74 years, female, NA, stage:III, dead, 413 days
1832.4
DO46400
70 years, female, NA, stage:III, dead, 719 days
1823.8
DO46392
48 years, female, NA, stage:III, dead, 628 days
1777.9
DO46528
56 years, female, NA, stage:III, alive, 6139 days
1713.1
DO46334
77 years, female, NA, stage:III, dead, 496 days
1710.7
DO46538
57 years, female, NA, stage:III, dead, 1527 days
1691.3
DO46386
49 years, female, NA, stage:III, dead, 1162 days
1672.7
DO46533
46 years, female, NA, stage:III, alive, 3667 days
1664.4
DO46561
52 years, female, NA, stage:III, dead, 195 days
1661.8
DO46352
60 years, female, NA, stage:III, dead, 677 days
1579.8
DO46518
62 years, female, NA, stage:III, alive, 2960 days
1529.6
DO46328
52 years, female, NA, stage:III, dead, 972 days
1528.8
DO46382
62 years, female, NA, stage:IV, dead, 311 days
1509.5
DO46354
73 years, female, NA, stage:III, dead, 843 days
1466.9
DO46330
60 years, female, NA, stage:III, dead, 684 days
1455.7
DO46358
60 years, female, NA, stage:III, dead, 423 days
1391.1
DO46591
58 years, female, NA, stage:III, dead, 195 days
1389.4
DO46508
50 years, female, NA, stage:III, dead, 2101 days
1375.7
DO46560
45 years, female, NA, stage:IV, dead, 286 days
1367.0
DO46588
74 years, female, NA, stage:III, dead, 438 days
1365.6
DO46356
68 years, female, NA, stage:III, dead, 911 days
1339.2
DO46443
59 years, female, NA, stage:III, dead, 2464 days
1302.7
DO46325
54 years, female, NA, stage:III, dead, 477 days
1300.3
DO46366
65 years, female, NA, stage:III, dead, 2054 days
1265.1
DO46380
51 years, female, NA, stage:III, dead, 1423 days
1232.2
DO46408
56 years, female, NA, stage:III, dead, 489 days
1219.1
DO46329
52 years, female, NA, stage:III, dead, 1699 days
1210.2
DO46348
58 years, female, NA, stage:IV, dead, 287 days
1192.0
DO46581
66 years, female, NA, stage:III, dead, 408 days
1184.3
DO46597
60 years, female, NA, stage:III, dead, 393 days
1179.0
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
1174.7
DO46432
56 years, female, NA, stage:III, alive, 2218 days
1143.7
DO46493
62 years, female, NA, stage:IV, alive, 839 days
1142.7
DO46350
66 years, female, NA, stage:III, dead, 886 days
1140.6
DO46376
58 years, female, NA, stage:III, dead, 1430 days
1073.9
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
1061.2
DO46362
61 years, female, NA, stage:III, dead, 1639 days
1033.8
DO46372
39 years, female, NA, stage:III, dead, 1326 days
977.8
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
976.7
DO46346
54 years, female, NA, stage:III, dead, 1187 days
962.0
DO46368
57 years, female, NA, stage:III, dead, 2879 days
907.6
DO46571
61 years, female, NA, stage:III, dead, 243 days
902.5
DO46398
66 years, female, NA, stage:III, alive, 437 days
876.0
DO46332
56 years, female, NA, stage:III, dead, 689 days
854.1
DO46404
55 years, female, NA, stage:III, dead, 690 days
835.6
DO46327
54 years, female, NA, stage:III, dead, 184 days
835.0
DO46396
64 years, female, NA, stage:III, dead, 583 days
833.6
DO46342
67 years, female, NA, stage:III, dead, 1398 days
831.6
DO46602
74 years, female, NA, stage:III, dead, 205 days
816.6
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
781.1
DO46412
64 years, female, NA, stage:III, dead, 597 days
771.6
DO46344
46 years, female, NA, stage:III, dead, 642 days
755.5
DO46468
67 years, female, NA, stage:III, alive, 2776 days
751.6
DO46374
69 years, female, NA, stage:III, dead, 1409 days
711.1
DO46448
45 years, female, NA, stage:III, dead, 654 days
663.9
DO46436
58 years, female, NA, stage:III, alive, 3193 days
648.4
DO46336
70 years, female, NA, stage:IV, dead, 664 days
645.9
DO46606
73 years, female, NA, stage:III, alive, 804 days
592.4
DO46340
62 years, female, NA, stage:III, dead, 616 days
537.7
DO46546
73 years, female, NA, stage:III, dead, 1889 days
289.7
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
284.8
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.2
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.1
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.0
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-0.1
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.2
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
-0.2
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.3
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.3
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.4
285fed94-1495-448e-879b-b55de9_D2
Tumor
-0.4
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.4
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-0.4
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.5
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.5
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-0.5
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
-0.5
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
-0.5
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.5
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-0.5
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.5
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
-0.6
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.6
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.6
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-0.6
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.6
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.7
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-0.7
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.7
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.7
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.7
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.7
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
-0.8
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
-0.8
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.8
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.8
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.8
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-0.9
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.9
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.9
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.9
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-0.9
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.9
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.9
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.9
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
-0.9
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-1.0
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-1.0
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-1.0
15524912-685a-47ce-a824-567848_D2
Tumor
-1.0
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-1.1
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-1.1
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-1.1
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-1.1
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-1.1
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-1.1
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-1.1
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-1.1
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-1.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-1.1
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
-1.1
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
-1.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-1.2
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-1.2
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
-1.2
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-1.2
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-1.3
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-1.3
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-1.3
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-1.3
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-1.3
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-1.3
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-1.3
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-1.4
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-1.4
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-1.4
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-1.4
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-1.4
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-1.4
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-1.4
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-1.5
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-1.5
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-1.5
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-1.5
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-1.5
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-1.6
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-1.6
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-1.6
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-1.6
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-1.6
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-1.6
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-1.6
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
-1.6
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-1.6
e9d416e7-f661-400a-896e-388545_D2
Tumor
-1.7
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-1.7
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-1.7
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-1.8
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-1.8
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-1.8
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-1.9
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-1.9
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-1.9
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-2.0
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-2.0
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-2.1
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-2.1
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-2.1
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-2.3
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
